Alzheimer's Panel
Overview
Alzheimer’s disease is a progressive neurodegenerative disorder that impacts memory,
cognition, and quality of life. Today, an estimated 6.9 million Americans aged 65 and older
are living with Alzheimer’s dementia, a number projected to rise to 13.8 million by 2060. While
symptoms often emerge later in life, the underlying biological changes begin decades earlier.
By analyzing a broad range of gene variants, this panel helps identify risk before symptoms
arise empowering both providers and patients to take proactive steps.
What This Test Covers
Our Panel is structured into six key categories, each addressing distinct pathways that influence Alzheimer’s disease risk and cognitive health:
Neurodegenerative Risk Genetics
- Clusterin-Associated Alzheimer’s Risk
- Overall Alzheimer’s Disease Susceptibility
- APOE Risk Scoring for Alzheimer Disease
Microbiome–Cognitive Health Profile
- Gut-Brain Resilience
Alzheimer’s Metabolic Risk Indicators
- Alzheimer’s Disease–Metabolic Interaction (AD-MI)
Homocysteine Regulation
- Homocysteine Elevation
Neuro-Immune Health
- Chronic Inflammation
Nutrient Metabolism Profiles
- Zinc
- Vitamin D
Why It Matters
Early detection of genetic risk can be a game-changer allowing for preventive strategies that delay or reduce disease progression. The Alzheimer’s Panel helps address this urgency by offering:
- A proactive lens into long-term cognitive risk, years before clinical signs appear.
- Precision insights across neuroinflammation, metabolism, and nutrient pathways.
- Prevention-first protocols for integrative, functional, and conventional medical approaches.
- Greater clarity for dementia clinics, neurologists, geriatric specialists, and cognitive health providers.
Who Should Take This Test
This panel is ideal for:
Adults with a family history of Alzheimer’s or dementia seeking proactive risk assessment.
Individuals experiencing early signs of cognitive decline or memory concerns
Functional and integrative medicine practitioners addressing brain aging at the root.
Neurologists and dementia clinics integrating genomics into diagnostic protocolssing cutting-edge genetic data.
Providers supporting patients with brain fog, emotional changes, or mood shifts
Anyone seeking to personalize brain health plans with precision-based insights
What You’ll Receive
Comprehensive Genetic Report
Organized into clear categories and subcategories, covering key health areas.
Personalized Insights
Actionable insights for nutrition, lifestyle, labs to consider and supplementation based on patients' unique genetic profile.
Provider Portal Access
Results are delivered digitally through the ExtendingME Provider Portal, ensuring seamless viewing, and sharing of reports.
SNP-Specific Risk Interpretations (optional, based on your requirements)
For providers seeking deeper genetic insights, we offer detailed SNP-level interpretations.
- Genetic marker identification (e.g., gene name, rsID)
- Patient genotype results and health implications
- Scientific explanation of how these genes influence specific health traits
Turnaround Time
Results will be available within 3 weeks from the receipt of the sample and will be securely delivered through the Provider Portal, enabling seamless access, viewing, and sharing of reports.
Collection Method
ExtendingME kits include all necessary self-collection devices for non-invasive, at-home saliva collection, making it easy to deliver real-time, data-driven healthcare solutions without the need for lab visits.
Take Action Before Symptoms Start
Early genetic insights. Smarter prevention. Personalized brain health powered by your DNA
